Part 2: High product value, short product shelf-life: Solving the Biopharma-supply chain conundrum through enhanced flexibility, visibility and responsiveness
Chris Roth, Director Corporate Planning, Amgen
Elisabeth Kaszas, Director Supply Chain, Corporate Planning, Amgen
Nari Viswanathan, VP Supply Chain Research, Aberdeen Group
Trevor Miles, Director Industry Applications Marketing, Kinaxis
Reducing waste in Biopharma operations is a key initiative for many supply chain leaders across the industry. High product values, highly regulated operations, limited product shelf-lives, and increasing focus on network effectiveness, make this a skilful balancing act to get right.
What are the methodologies and systems that are enabling some of the most advanced Biopharma supply chains to adapt and respond to changing customer demands, reduce inventory and improve financial performance whilst cutting waste and maintaining high service levels?
This on-demand will examine all of these issues, and give participants a framework of processes, tools and examples to help drive significant improvements within your global operation.